跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,138 条关于
“BCR-ABL tyrosine kinase”
全部
13,138
临床试验
8,681
药物
1,534
机构
340
资讯
2,583
去年
FDA Grants Breakthrough Therapy Designation to Olverembatinib for Ph+ Leukemia Treatment
2年前
Novartis' Scemblix Demonstrates Superior Efficacy in Newly Diagnosed CML Patients
去年
Terns Pharmaceuticals Advances CML Drug TERN-701 and Obesity Treatment TERN-601 in Clinical Trials
上个月
Ascentage Pharma CEO Dr. Dajun Yang Ranked No. 3 on The Medicine Maker Power List 2026 in Small Molecules
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
6个月前
Digital PCR Outperforms Standard RT-qPCR in Detecting Residual BCR::ABL1 in CML Patients, Enabling Better TKI Discontinuation Decisions
9个月前
Terns Pharmaceuticals Closes $747.5 Million Public Offering to Advance BCR-ABL Inhibitor TERN-701
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
第 1 页,共 259 页
上一页
下一页